NO2729579T3 - - Google Patents

Info

Publication number
NO2729579T3
NO2729579T3 NO12732686A NO12732686A NO2729579T3 NO 2729579 T3 NO2729579 T3 NO 2729579T3 NO 12732686 A NO12732686 A NO 12732686A NO 12732686 A NO12732686 A NO 12732686A NO 2729579 T3 NO2729579 T3 NO 2729579T3
Authority
NO
Norway
Application number
NO12732686A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2729579T3 publication Critical patent/NO2729579T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO12732686A 2011-07-08 2012-07-09 NO2729579T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161505919P 2011-07-08 2011-07-08

Publications (1)

Publication Number Publication Date
NO2729579T3 true NO2729579T3 (fr) 2018-03-03

Family

ID=46458553

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12732686A NO2729579T3 (fr) 2011-07-08 2012-07-09

Country Status (21)

Country Link
US (4) US10626462B2 (fr)
EP (1) EP2729579B1 (fr)
JP (1) JP6397762B2 (fr)
KR (1) KR102046668B1 (fr)
CN (2) CN108048573A (fr)
AU (1) AU2012282528B2 (fr)
BR (1) BR112014000443B1 (fr)
CA (1) CA2840149C (fr)
DK (1) DK2729579T3 (fr)
EA (1) EA034232B1 (fr)
ES (1) ES2654561T3 (fr)
HR (1) HRP20180001T1 (fr)
HU (1) HUE036036T2 (fr)
IL (1) IL230303B (fr)
LT (1) LT2729579T (fr)
MX (1) MX358117B (fr)
NO (1) NO2729579T3 (fr)
PH (1) PH12014500063A1 (fr)
SI (1) SI2729579T1 (fr)
WO (1) WO2013007702A1 (fr)
ZA (1) ZA201400089B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
CA2951141C (fr) * 2014-06-04 2021-11-30 Quest Diagnostics Investments Incorporated Marqueurs methyles pour le cancer colorectal
CN104745575B (zh) * 2014-08-08 2019-03-12 博诚研究中心 用于检测细胞增殖性异常或疾病程度分级的基因组合物及其用途
EP3766986B1 (fr) 2014-12-31 2022-06-01 Guardant Health, Inc. Détection et traitement d'une maladie faisant preuve d'hétérogénéité des cellules malades et systèmes et procédés de communication des résultats de test
CN106148501A (zh) * 2015-04-23 2016-11-23 博诚研究中心 一种检测Septin9基因甲基化的试剂盒及其应用
US20180187246A1 (en) * 2015-07-15 2018-07-05 Universiteit Gent Probes and a methylation in situ hybridization assay
JP6897970B2 (ja) * 2015-09-08 2021-07-07 国立大学法人山口大学 大腸腫瘍の有無を検査する方法
US11566284B2 (en) 2016-08-10 2023-01-31 Grail, Llc Methods of preparing dual-indexed DNA libraries for bisulfite conversion sequencing
WO2018195217A1 (fr) 2017-04-19 2018-10-25 Singlera Genomics, Inc. Compositions et procédés pour la construction de bibliothèques et l'analyse de séquences
CN107385056A (zh) * 2017-08-10 2017-11-24 上海时代基因医学科技有限公司 一种检测SEPT9基因不同Cpg岛甲基化的试剂盒及应用
WO2019076949A1 (fr) * 2017-10-18 2019-04-25 Deutsches Krebsforschungszentrum Moyen et procédés de classification des cancers colorectaux
WO2019108568A1 (fr) * 2017-11-29 2019-06-06 The Regents Of The University Of Michigan Compositions et procédés de caractérisation du cancer
CN108796080B (zh) * 2018-06-06 2022-06-07 苏州唯善生物科技有限公司 用于结直肠癌诊断、检测或筛查的引物和探针组
CN109055552A (zh) * 2018-08-23 2018-12-21 北京迈基诺基因科技股份有限公司 检测Septin9基因启动子是否甲基化的方法及其专用成套试剂
CN112195243A (zh) * 2020-09-22 2021-01-08 北京华大吉比爱生物技术有限公司 一种检测多基因甲基化的试剂盒及其应用
KR102404750B1 (ko) 2021-10-14 2022-06-07 주식회사 엔도믹스 세포 유리 dna를 이용한 대장암 진단을 위한 메틸화 마커 유전자 및 이의 용도
CN114561452A (zh) * 2022-03-10 2022-05-31 天津市人民医院 mSEPT9作为预测结直肠癌患者术后复发风险标志物及用于评价化疗方案有效性的应用
KR102559496B1 (ko) * 2022-04-26 2023-07-25 연세대학교 산학협력단 핵산의 메틸화 여부 확인용 조성물 및 핵산의 메틸화 여부를 확인하는 방법
CN115248313A (zh) * 2022-08-03 2022-10-28 中山市人民医院 肠癌外周血免疫细胞m5C标志物的应用
CN115029462B (zh) * 2022-08-10 2022-11-08 中国农业科学院农业质量标准与检测技术研究所 一种动植物疫病的核酸标准物质、形貌模拟方法及其应用
CA3268032A1 (fr) * 2022-09-23 2024-03-28 Flagship Pioneering Innovations Vi, Llc Procédés d'amplification d'acides nucléiques
WO2024107441A1 (fr) * 2022-11-14 2024-05-23 Trustees Of Dartmouth College Biomarqueurs systémiques pour l'évaluation dynamique de la charge tumorale et de l'efficacité du traitement dans les gliomes de haut grade

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US412900A (en) 1889-10-15 roaers
US150000A (en) 1874-04-21 Improvement in cigar mouth - pieces
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
EP0734436B1 (fr) 1993-11-30 1999-04-14 McGILL UNIVERSITY Inhibition de la methyltransferase de l'adn
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6251594B1 (en) 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
CN1150317C (zh) * 1999-08-10 2004-05-19 中国医学科学院肿瘤医院肿瘤研究所 一种食管癌相关新基因
WO2002024056A2 (fr) * 2000-09-20 2002-03-28 Case Western Reserve University Procedes et compositions servant a detecter des cancers associes a la methylation de l'adn du promoteur hmlh1
DE10112515B4 (de) 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
CN1187456C (zh) * 2001-11-27 2005-02-02 暨南大学 CpG岛甲基化检测试剂盒及其应用
DE10348407A1 (de) * 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
CA2549852A1 (fr) 2003-12-11 2005-06-30 Epigenomics Ag Procede et acides nucleiques permettant un traitement ameliore des troubles proliferatifs des cellules mammaires
JP4765058B2 (ja) 2004-12-13 2011-09-07 国立大学法人 岡山大学 核酸修飾前の検体の前処理方法
EA013634B1 (ru) 2005-04-15 2010-06-30 Эпиджиномикс Аг Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений
WO2007085497A2 (fr) 2006-01-30 2007-08-02 Epigenomics Ag Marqueurs de prévision des résultats d'un traitement à l'anthracycline
CA2649777C (fr) * 2006-04-17 2018-08-14 Epigenomics Ag Procedes et acides nucleiques pour detecter des troubles de proliferation de cellules colorectales
US9939441B2 (en) * 2006-07-21 2018-04-10 Epigenomics Ag Methods and nucleic acids for analyses for cellular proliferative disorders
WO2008100913A2 (fr) * 2007-02-12 2008-08-21 The Johns Hopkins University Détection précoce et pronostic de cancers du côlon
JP5378687B2 (ja) 2007-03-02 2013-12-25 エフ.ホフマン−ラ ロシュ アーゲー Basp1遺伝子および/またはsrd5a2遺伝子中のメチル化シトシンを利用する、肝臓癌、肝臓癌発症リスク、肝臓癌再発リスク、肝臓癌悪性度および肝臓癌の経時的進展の検出方法
CN102159728A (zh) 2008-09-19 2011-08-17 希森美康株式会社 乳腺癌转移的判断方法及血清的评价方法
US8497066B2 (en) * 2008-12-04 2013-07-30 Rush University Medical Center DNA methylation based test for monitoring efficacy of treatment
EP2309005B1 (fr) * 2009-08-03 2015-03-04 Epigenomics AG Procédés pour la conservation de la complexité de la séquence d'ADN génomique

Also Published As

Publication number Publication date
US20150031021A1 (en) 2015-01-29
MX2014000116A (es) 2014-03-27
US12110558B2 (en) 2024-10-08
EA201400117A1 (ru) 2014-06-30
JP6397762B2 (ja) 2018-09-26
CA2840149C (fr) 2021-10-26
ES2654561T3 (es) 2018-02-14
MX358117B (es) 2018-08-06
HUE036036T2 (hu) 2018-06-28
US20200308656A1 (en) 2020-10-01
HRP20180001T1 (hr) 2018-03-09
KR102046668B1 (ko) 2019-11-19
ZA201400089B (en) 2022-03-30
BR112014000443B1 (pt) 2021-03-23
EA034232B1 (ru) 2020-01-20
CA2840149A1 (fr) 2013-01-17
SI2729579T1 (en) 2018-07-31
IL230303B (en) 2018-05-31
AU2012282528B2 (en) 2017-04-13
CN103732759A (zh) 2014-04-16
US11261499B2 (en) 2022-03-01
EP2729579A1 (fr) 2014-05-14
WO2013007702A1 (fr) 2013-01-17
DK2729579T3 (en) 2018-01-08
JP2014520520A (ja) 2014-08-25
LT2729579T (lt) 2018-02-26
US20250101527A1 (en) 2025-03-27
KR20140044385A (ko) 2014-04-14
US10626462B2 (en) 2020-04-21
CN108048573A (zh) 2018-05-18
EP2729579B1 (fr) 2017-10-04
PH12014500063A1 (en) 2014-02-17
US20220243277A1 (en) 2022-08-04
AU2012282528A1 (en) 2014-01-23
BR112014000443A2 (pt) 2017-02-14

Similar Documents

Publication Publication Date Title
BR112013022641A2 (fr)
BR112013031251A2 (fr)
BR112013027245A2 (fr)
BR112013024383A2 (fr)
BR112013026905A2 (fr)
BR112013023185A2 (fr)
BR112013022995A2 (fr)
BR112013017670A2 (fr)
BR112013027830A2 (fr)
BR112013026744A2 (fr)
AP3853A (fr)
BR112013023927A2 (fr)
BR112013027452A2 (fr)
BR112013024365A2 (fr)
BR112013028733A2 (fr)
BR112013027121A2 (fr)
AP2016009466A0 (fr)
BR112013031556A2 (fr)
BR112013026790A2 (fr)
BR112013024588A2 (fr)
BR112013032366A2 (fr)
NO2729579T3 (fr)
BR112013032377A2 (fr)
BR112013032380A2 (fr)
BR112013027836A2 (fr)